Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FR09U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,626
Award facts
- Contract value 100% obligated
- $40,626.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $40,626.04 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors on January 14, 2026, with an ultimate completion date of January 15, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor medication used for managing high cholesterol and reducing cardiovascular risk in military personnel and veterans. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significantly larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently supply a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. As a competitively-awarded prime contractor without set-aside designation, AmerisourceBergen continues to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles that address the evolving pharmaceutical supply needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FR09U?
SPE2DR26FR09U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FR09U worth?
The government has obligated $40,626 on SPE2DR26FR09U.
Is contract SPE2DR26FR09U an order under another contract?
Yes. SPE2DR26FR09U is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR09U competed?
The extent of competition for SPE2DR26FR09U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award